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Background: Chronic obstructive pulmonary disease (COPD) patients have lower levels of phys-
ical activity compared to age-matched controls, and they limit physical activities requiring
normal exertion. Our purpose was to compare the effectiveness of a traditional exercise
therapy (TET) program with a behavioral lifestyle activity program (LAP) in promoting physical
activity.
Methods: Moderate physical activity (kcal/week) was assessed in 176 COPD patients using the
Community Health Activities Model for Seniors questionnaire. Patients were randomized to
either a three month TET program that meet thrice weekly or a LAP. The LAP was designed
to teach behavioral skills that encouraged the daily accumulation of self-selected physical
activities of at least moderate intensity. Interventionist contact was similar (36 h) between
the two groups. Patients were assessed at baseline and 3, 6 and 12 months.
Results: Compared to baseline values, self-reported moderate physical activity increased three
months post-randomization with no significant difference (pZ 0.99) found between the TET
(2501  197 kcal/week) and the LAP (2498  211 kcal/week). At 6 and 12 months post-
randomization, there were no significant differences (pZ 0.37 and 0.69, respectively) in self-
reported levels of moderate physical activity between the TET (2210 187 and 2213 218 kcal/
week, respectively) and the LAP (2456 198 and 2342 232 kcal/week, respectively).
Conclusion: Although there was no difference between treatment groups, the TET and the LAP
were both effective at in increasingmoderate levels of physical activity at 3 months andmaintain-
ing moderate physical activity levels 12 months post-randomization.332 and M01 RR07122 from the National Institutes of Health (Bethesda, MD).
758 5847; fax: þ1 336 758 4680.
(M.J. Berry), rejeski@wfu.edu (W.J. Rejeski), mmiller@wfubmc.edu (M.E. Miller), nadiar@wfubmc.
(C.G. Lang), cfoy@wfubmc.edu (C.G. Foy), katulaj@wfu.edu (J.A. Katula).
0 Elsevier Ltd. All rights reserved.
830 M.J. Berry et al.This clinical trial is registered with ClinicalTrials.gov. Its identifier is NCT00328484.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) patients
report limitations in physical activities requiring normal
exertion30 and lower physical activity levels when compared
to age-matched healthy adults.22,25,34 Consequently, COPD
patients experience decreases in physical function and
quality of life resulting in further inactivity and a cycle of
further deconditioning. Short-term exercise therapy can
interrupt this cycle and improve physical function and
quality of life.20,21,32 Furthermore, results contrasting short-
term (3 months) and long-term (18 months) exercise therapy
has demonstrated the superiority of long-term therapy on
improved physical function and quality of life.5,11 Recent
data from Garcia-Aymerich et al. have shown that regular
physical activity is associated with a reduction in COPD
hospitalizations and respiratory mortality.12 Collectively,
these data support the benefit and need of promoting long-
term physical activity in COPD patients.
Unfortunately long-term adherence with exercise
programs for individuals with a chronic disease mirrors the
unfavorable reports found in asymptomatic populations.23
Given that the current exercise therapy model for COPD
patients is to provide 8e12 weeks of center-based exercise
therapy with no additional intervention,13 the goal of the
present study was to contrast this approach with a lifestyle
activity program (LAP) on long-term (12 month) maintenance
of physical activity levels in COPD patients. The LAP, based on
our past successful experience with a similar program devel-
oped for individuals at risk for or those with cardiovascular
disease,26 was designed to phase out supervised, center-
based activity over an initial 3-month period using behavior
change procedures that encouraged patients to increase their
daily physical activity levels such that they met established
physical activity guidelines.1,40 Our hypothesis was that the
LAPwould result in higher levels ofmoderate physical activity
at the end of 12 months as compared to a traditional three-
month exercise therapy (TET) program.Methods
Design
This was a single center, single blind, randomized
controlled clinical trial. Patient were recruited over a 4-
year period in waves of approximately 12e15 patients per
wave via community based advertising in the local media
and physician referral. No financial remuneration was
offered to patients for their participation, and all patients
were informed they had the option to drop out of the study
at any time with no adverse effects on their treatment.
Patients within each wave were randomized to either the
LAP or the TET following completion of baseline visits.
Evaluation of participants occurred at baseline and at 3, 6
and 12 months post-randomization. Staff members blindedto the participant’s treatment assignment completed all
data collection. All analyses allocated participants to their
originally randomized groups and used all available follow-
up data.
Participants
Participants were eligible if they had an expiratory airflow
limitation such that the FEV1/FVC was 70% and the FEV1
was 20% of predicted. Patients had to report difficulty in
performing at least one of the following activities due to
dyspnea: walking a city block, grocery shopping, doing
household chores, lifting objects chest height or higher,
walking up stairs and getting out of a chair. Patients had to
be free of severe cardiovascular or peripheral vascular
disease, not undergoing active treatment for cancer, free
from uncontrolled hypertension or diabetes, have not
participated in a pulmonary rehabilitation or exercise
program for the previous three months, and be willing to
accept random assignment into either intervention arm.
Determination of medical diagnoses which would preclude
participation in the study was done through a medical
history, physical exam and a graded exercise test. All
participants remained under the care of their personal
physician and signed an informed consent approved by the
University’s Institutional Review Board.
Behavioral run-in
Because the LAP required participants to engage in self
monitoring of physical activity for 12months, all participants
completed a one week behavioral run-in prior to randomi-
zation. Participants were asked to record information
regarding their levels of physical activity during this period
and were queried as to their perceived difficulty with this
process. They were also questioned about their willingness
to continue this process for an additional 12 months. Those
that were unable to perform self monitoring during this one
week period or unwilling to continue this process for an
additional 12 months were excluded from the study.
Randomization
Randomization was performed using a web-based random-
ization application. All baseline measurements were
obtained prior to randomization. Only the statisticians were
unblinded to the randomization scheme, which was strati-
fied by gender and study period (1st, 2nd, and final third of
participants randomized). Block sizes varied randomly
between 4 and 6.
Power
This study was designed to have 90% power to detect
a 400 kcal/week average difference during follow-up with
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between baseline and follow-up measurements was 0.60 as
observed by Stewart et al.,38 and 85% power if the corre-
lation was 0.50.Interventions
Both the LAP and the TET groups received identical center-
based exercise therapy and bimonthly education classes at
the clinic site during the first three months of the study.
Both interventions had 36 contact hours between inter-
ventionists and participants. The TET group met for 1-hour
exercise sessions thrice weekly for 12 weeks. Each session
consisted of a brief warm-up, 30e35 min of walking at
a rating of perceived dyspnea of 3e5 (moderate to some-
what hard) on the Borg categorical scale,6 10e15 min of
strength training using elastic resistance bands and a brief
cool-down. Following completion of the 36 center-based
sessions, participants were encouraged to continue exer-
cising; however, an option to continue at the clinic site was
not provided. Participants were provided information on
community sites that conducted similar programs similar to
the one completed.
The LAP also consisted of 36 h of participant contact;
however, the structure, timing, and goals of these sessions
differed from the TET. A basic principle underlying these
contacts and their sequencing was one of gradually weaning
participants from the dependency on staff and the center-
based program toward independent promotion and self-
regulation of physical activity at home. This process was
one of a phased increase in the ratio of personal responsi-
bility in conjunction with a phased decrease in staff, group
and clinic dependency. In the LAP intervention, the prin-
ciples of group dynamics were used to systematically
develop group formation and identity, create the group’s
common motivational base (i.e., independent physical
activity), and establish exercise and adherence expectan-
cies in members that were of consequence to the group. In
other words, the group was used to promote an indepen-
dent lifestyle of physical activity by (a) making this the
group goal, (b) teaching and practicing this approach within
the group, (c) gaining commitment to independent exercise
for each member from within the group, and then, (d)
avoiding group dependence by weaning participants from
the group so that these individuals sustain independent,
long-term, daily activity at home and/or in the community.
For the LAP, there were four different types of contacts
that the patients had with the staff to help establish the
above goals. The first of these was center-based exercise/
group sessions. During center-based exercise/group
sessions, participants met at the rehabilitation facility for
1 hour of center-based exercise training. These exercise
sessions were the same as those used with the TET
program. Following the exercise sessions, participants
engaged in a 15-min period of instruction and participated
in group discussion regarding the self-regulatory aspect of
learning long-term maintenance of physical activity. The
second type of contact the LAP patients had with staff was
center-based exercise training sessions. During center-
based exercise training sessions, participants met at the
rehabilitation facility for 1 h exercise training. The thirdtype of contact patients had with staff was 30 min indi-
vidual counseling sessions to review and evaluate the
patient’s ability to sustain independent long-term physical
activity. The fourth type of contact patients had with staff
was 15 min individual phone contacts to review and eval-
uate the patient’s progress in sustaining physical activity.
When center-based training sessions were being
reduced, patients were encouraged to increase home-
based training so that total weekly exercise sessions
occurred three times per week. This home-based training
was prescribed at an intensity comparable to center-based
training. However, patients were told that their exercise
sessions could be divided into smaller units of no less than
10 min. Thus, participants might choose to perform their
home exercise using four 10-min bouts, two 20-min bouts or
a single 40-min bout. Patients in the LAP group were given
instruction in and assistance in planning for goals that
included integrating alternative physical activities into
their daily lifestyles. This involved activities such as yard
work, choosing to use stairs rather than elevators, taking
the option of walking instead of sitting to wait for someone,
and/or becoming more involved in recreational sports
activities. The objective was to make daily living as active
as possible emphasizing that benefits can also be obtained
from physical activity that is moderate in intensity and, in
some instances, relatively brief.
The timing of all patient contact for the LAP was
structured so the patients would not have contact with the
staff for one month prior to a follow-up testing visit. A
detailed description of the TET and LAP contacts is shown in
Table 1.Primary outcome
Assessment of the primary outcome and all secondary
outcomes were performed by assessors blinded to the
patients’ treatment randomization. The primary outcome
was weekly energy expenditure from moderate physical
activity measured as kcals/week as estimated using the
Community Health Activities Model Program for Seniors
(CHAMPS) physical activity questionnaire.38 The CHAMPS
was specifically designed to assess physical activity of older
adults and to evaluate interventions designed to increase
physical activity in older adults. It has been shown to be
appropriate for use across diverse samples of older adults
and to be sensitive to change in a number of studies with
older adults.18,31,38,39 It is interviewer administered and
comprised of 41 items of which 27 pertain to physical
activity and are used for scoring. From the instrument,
typical weekly energy expenditure (kcal/week) and
frequency of moderate and total physical activity can be
estimated. Six-month intraclass correlation coefficients for
energy expenditure in all and moderate activities were 0.66
and 0.67, respectively.38 While the CHAMPS defines
moderate physical activity as a metabolic equivalent (MET)
of 3 or more, we defined moderate physical activity as any
activity with a MET value greater than 1.84 METs. Our
rationale for doing this was based on the fact that
moderate physical activity is defined in Physical Activity
and Health: A Report of the Surgeon General as any activity
requiring an intensity greater than or equal to 45% of the
Table 1 LAP and TET contact schedule.
Month LAP contacts Contact
hours
Total contact
hours
TET contacts Contact
hours
Total contact
hours
1 6 Center-based exercise/group session 7.50 7.50 12 Center-based
exercise sessions
12 12
2 1 Individual counseling session
4 Center-based exercise/group session
0.50
5.00
13.0 12 Center-based
exercise sessions
12 24
3 1 Individual phone contact
3 Center-based exercise/group session
0.25
3.75
17.0 12 Center-based
exercise sessions
12 36
4 1 Individual counseling session
3 Center-based exercise/group session
0.50
3.75
21.25
5 1 Individual phone contact
3 Center-based exercise/group session
0.25
3.75
25.25
6 1 Individual counseling session
2 Center-based exercise/group session
0.50
2.5
28.25
7 2 Center-based exercise/group session 2.5 30.75
8 2 Center-based exercise/group session 2.5 33.25
9 1 Individual phone contact
1 Center-based exercise session
0.25
1.00
34.5
10 1 Individual phone contact
1 Center-based exercise session
0.25
1.00
35.75
11 1 Individual phone contact 0.25 36.00
12 0 Contacts 0 36.00
832 M.J. Berry et al.maximal MET capacity.40 The average measured maximal
MET capacity of the participants in this current investiga-
tion measured during their baseline visit was 4.1 METs. Thus
45% of 4.1 METs was 1.84 METs.Secondary outcomes
Physical function
Physical function was assessed using a series of tests that
have all been used previously with COPD patients.2,10,15,28
These included the 6 min walk distance, stair climb time
and the Short Physical Performance Battery (SPPB) which
consisted of a 4 m walk speed, chair rise time and balance
time. The 6 min walk was performed in a dedicated
gymnasium that measured 8 m by 14 m according to the
guidelines of the American Thoracic Society.2 For the timed
stair climb, participants were asked to ascend two flights of
stairs as quickly as possible while holding onto the handrail.
Each step had a 7 inch rise and a 12 inch run. The total
vertical ascent was 12.6 ft. The participants did not receive
encouragement or feedback on their performance.
Walking speed in the SPPB was assessed by asking the
participants to walk at their usual pace over 4 m. Partici-
pants were allowed to use walking aids (cane, walker, or
other walking aid) if necessary, but not the assistance of
another person. Time in seconds needed to complete the
entire distance was recorded. Two trials were administered
and the faster of the two was used to compute walking
speed. The chair rise test was performed using a straight-
backed chair placed with its back against a wall. Partici-
pants were first asked to stand from a sitting position
without using their arms. If they were able to perform the
task, they were then asked to stand up and sit five times as
quickly as possible. The time to complete the task wasrecorded. For the test of standing balance, participants
were asked to maintain balance in three positions charac-
terized by a progressive narrowing of the base support: feet
together (side by side position), the heel of one foot beside
the big toe of the other foot (semi tandem position), and
the heel of one foot in front of and touching the toes of the
other foot (tandem position). For each of the three posi-
tions, participants were timed to a maximum of 10 s. Scores
are summed for the measure of balance for a range of 0e
30 s. Each of the three performance measures was assigned
a score ranging from 0 to 4, with 4 indicating the highest
level of performance and 0 the inability to complete the
test according to the recommendations of Guralnick.15 A
summary performance score ranging from 0 (worst
performers) to 12 (best performers) was calculated by
adding walking speed, chair stands and standing balance
scores. This scale has proven valid for predicting institu-
tionalization, hospital admission, mortality and
disability.14,15
Self-reported disability
Self-reported disability was determined using a 23-item
questionnaire that assessed the physical disability of the
participant. For each item, participants were queried as to
how much difficulty they experienced while performing
physical activities during the past month. The question-
naire is scored on a 6-point scale with a score of one indi-
cating ‘‘usually did with no difficulty’’ and a score of six
indicating ‘‘usually did not do for other reasons.’’27,29
Health-related quality of life
Health-related quality of life was measured using both
generic8,37 and a disease-specific instruments.16 Psycho-
logical functioning was assessed using the short form of the
CESD,8 whereas subscales from the RAND 36-item Health
Lifestyle activity in COPD patients 833Survey37 were used to assess general health, pain and social
functioning. The Chronic Respiratory Disease Questionnaire
was used as a disease-specific measure of health-related
quality of life.16 This measure assessed quality of life in the
domains of dyspnea, mastery, fatigue and emotion.
Exercise capacity
Exercise capacity was expressed as peak oxygen consump-
tion ( _VO2 peak) and total time during a graded exercise test
performed on a treadmill.4 Peak oxygen consumption was
determined during a graded exercise test performed in the
morning prior to the use of any bronchodilators. Each
patient performed a modified Naughton protocol on
a treadmill (Quinton Q-4000) in which the grade and/or belt
speed was increased by a specified amount at 2-min stages.
Oxygen consumption was measured using a Medical
Graphics Corporation CPX-D metabolic cart. All values were
collected during a 60-second period and reported as minute
values. The highest oxygen consumption value measured
for a complete 60-second period represented the _VO2 peak.
Calibration of the system occurred prior to every test
according to the manufacturer’s specifications. All cali-
bration gases were certified standard gases verified via
Haldane analysis.
Pulmonary function
Pulmonary function tests and lung volume determinations
were performed according to ATS guidelines using a Medical
Graphics Corporation 1085D plethysmograph.3
Compliance
Compliance was defined as the number of sessions
completed divided by the total number of sessions
prescribed and was expressed as a percentage. Compliance
was calculated based on all randomized patients. If
a participant planned to miss a session, an exercise leader
prepared an exercise prescription for that participant to
perform while away and verified compliance once the
participant returned.
Safety monitoring
Serious adverse events were defined based on the Code of
Federal Regulations, 21CFR 312.32 and included any of the
following outcomes: death, a life-threatening adverse
event, inpatient hospitalization or prolongation of existing
hospitalization, or a persistent or significant disability/
incapacity.
Statistical analysis
Baseline characteristics were compared between groups
using chi-square tests for categorical variables and the two
sample t-test for continuous variables.
An examination of the compliance data revealed non-
normal distributions. As a result median data are reported
for this measure.
The effect of the intervention on the primary outcome
averaged across both follow-up measurements was
analyzed using mixed effects analysis of covariance modelsfor repeated outcomes. The model testing this hypothesis
included factors used to stratify randomization ((gender,
study period (1st, 2nd, and final third of participants
randomized)), the baseline measure of energy expenditure,
the intervention effect, and a factor measuring the time
effect (3 months, 6 months, and 12 months) and an inter-
vention by time interaction term. An unstructured covari-
ance matrix was used to account for covariance between
repeated measures and estimation was done using
maximum likelihood. Follow-up means were estimated as
least squares means. The primary hypothesis was tested as
a contrast representing the difference in the average effect
between intervention groups across all time points, using
a two-sided 0.05 level of Type I error.
Secondary analyses of the primary and secondary
outcomes were conducted for differential effects of the
intervention at different follow-up points (i.e. an interac-
tion between the intervention effect and the time effect).
Results
Recruitment occurred over a three year period. Participant
flow is illustrated in Fig. 1. Following the screening visits, 176
individuals were randomized to either the LAP (nZ 87) or TET
(n Z 89). There were no differences between the groups in
the baseline characteristics shown in Table 2. When
comparing baseline characteristics between those that
dropped out versus those that completed the study, the drop
outs were significantly younger and there were a relatively
lower percentage with co-morbidity illness. There were no
other differences between these two groups. During the
course of the study, 24 patients dropped out of the LAP
program, and 20 dropped out of the TET program. Drop out
rateswerenot significantly different between the twogroups.
Compliance with the interventions
Compliance data were not normally distributed, therefore
median data are reported. Compliance with the TET was
80.6 percent and with the LAP was 74.3 percent. Results
from the Wilcoxon test showed these values not to be
significantly different (p Z 0.21).
Moderate physical activity
Fig. 2 illustrates moderate physical activity levels. Over 12
months, physical activity levels were not significantly
different between the LAP and TET groups (p Z 0.57,
average effect across all follow-up visits). The adjusted
difference in physical activity levels (kcals/week) between
the two groups was 3 at 3 months (p Z 0.99), 246 at 6
months (pZ 0.37) and 129 at 12 months (pZ 0.69). Within
the LAP group, there were significant increases in moderate
physical activity when comparing 3 (p Z 0.004), 6
(p Z 0.005) and 12 month (p Z 0.048) follow-up data to
baseline values. Within the TET group, there were signifi-
cant increases in moderate physical activity when
comparing 3 (pZ 0.002) and 6 month follow-up (pZ 0.039)
data to baseline values. For the TET, 12 month follow-up
physical activity levels were not significantly different from
baseline values (p Z 0.089).
Pre-screened for Eligibility
n = 958
Screened for Eligibility
n = 708
Entered Run-In
n = 177
Randomized
n = 176
Excluded (n = 250)
Did not meet eligibility criteria: 77
Not interested: 65
Other: 108
Excluded (n = 531)
Did not meet PFT criteria: 241
Not Interested: 216
Cardiac condition: 16
Other: 58
Excluded (n = 1):  Did not comply 
with behavioral run-in
LAP (n = 87)
Received Intervention: n = 84
Did not receive intervention: n =  3
TET (n = 89)
Received Intervention: n = 87
Did not receive intervention: n =  2
Dropped Out (n = 24)
Medical Condition: 2 
Personal/Time Commitments: 16
Lost to follow-up: 3
Other: 3
Dropped Out (n = 20)
Medical Condition: 6 
Personal/Time Commitments: 10
Lost to follow-up: 3
Other: 1
Analyzed (n = 61)
Excluded CHAMPS data: 2*
Missing CHAMPS: 20 at 3 months, 
20 at 6 months, 24 at 12 months
Analyzed (n = 69)
Excluded CHAMPS data: 0
Missing CHAMPS: 14 at 3 months, 
16 at 6 months, 20 at 12 months
Figure 1 * CHAMPS data from two participants was excluded from analysis due to improper administration of the baseline
questionnaire to the participants. Given baseline values were used as a covariate, data from these participants were also excluded
from the follow-up analysis. An analysis that did not control for baseline CHAMPS levels, but included all follow-up data for these
participants produced similar results and did not change the overall conclusions.
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Table 3 provides the results for measures of physical function.
Over 12months of follow-up, none of themeasures of physical
function were significantly different between the LAP and the
TET groups. Therewere no significant differences inmeasures
of physical function between the groups at any of the follow-
up time points. Within group analysis showed significant
improvements in selected measures of physical function for
both groups. More specifically, the TET had significant
improvements in 6-min walk distance, stair climb time, SPPB
score, 4-m walk distance and chair rise times at 3 months as
compared to baseline. The TET group maintained improve-
ments in 6-min walk distance, SPPB, 4-m walk distance and
chair rise time at 12 months. The LAP had significant
improvements in 6-min walk distance, SPPB score, 4-m walk
distance and chair rise times at 3 months as compared to
baseline. The LAP group maintained improvements in SPPB
score, 4-m walk distance and chair rise time at 12 months.Self-reported disability
Fig. 3 illustrates estimated mean levels of self-reported
disability. Over 12 months of follow-up, self-reported
disability levels were not significantly different between
the groups (p Z 0.91 for average effect across all follow-
up visits). There were no significant differences in self-
reported disability levels between the two intervention
groups at 3 (p Z 0.46), 6 (p Z 0.74) or 12 months
(pZ 0.97) of follow-up. Within the LAP group, there were
no significant differences in self-reported disability when
comparing 3 (p Z 0.23), 6 (p Z 0.23) and 12 month
(p Z 0.43) follow-up data to baseline values. Within the
TET group, there were significant increases in self-
reported disability when comparing 3-month follow-up
(pZ 0.027) data to baseline values. For the TET, 6 and 12
month follow-up self-reported disability were not signifi-
cantly different from baseline values (p Z 0.44 and 0.43,
respectively).
Table 2 Participant characteristics.
Characteristics TET LAP P Value
Men/Women, n/n 48/41 47/40 0.99
Age, yr (mean  SD) 66  10 66  10 0.96
Mass, kg (mean  SD) 84.4  23.9 82.2  20.3 0.50
Pulmonary function (mean  SD)
FEV1 (l) 1.48  0.63 1.46  0.69 0.79
FEV1 (% of predicted) 53.0  18.5 50.5  20.2 0.41
FEV1/FVC (%) 52.3  12.2 51.1  13.6 0.55
RV/TLC (%) 56.6  13.0 58.7  11.6 0.40
Disease severity (n with)
Mild 5 7 0.56
Moderate 44 34 0.26
Severe 30 33 0.71
Very severe 10 13 0.53
Smoking status
Current, n 26 29 0.51
Previous, n 59 53
Pack years (mean  SD) 24  12 27  17 0.23
Co-morbid illnesses (n with)
Arthritis 49 35 0.06
Hypertension 47 39 0.30
Circulatory Problems 17 16 0.90
Heart disease 39 40 0.77
Diabetes 8 14 0.15
Cancer 20 20 0.93
Co-morbid (n with)
0 10 18 0.29
1 18 16
>2 30 27
The p values for comparing the two treatment arms were obtained using the Chi-square test for categorical variables and the two sample
t-test for continuous variables. FEV1 is the forced expiratory volume in 1 s. FVC is the forced vital capacity. RV is the residual volume.
TLC is the total lung capacity.
Lifestyle activity in COPD patients 835Quality of life
Table 4 contains quality of life results. Over 12 months of
follow-up, quality of life measures were not significantlyMonth
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Figure 2 Moderate physical activity levels in kcals per week
by intervention arm at baseline and follow-up. Data are
reported as mean  standard error of the mean. Means were
estimated from mixed effects analysis of covariance for
repeated measures adjusted for gender and baseline values.different between the groups. There were no significant
differences in quality of life measures between the groups
at any of the follow-up time points. The TET had significant
improvements in the SF-36 physical scale and the CRQ at 3
months as compared to baseline. The TET group maintained
improvements in the CRQ at 12 months. The LAP had
significant improvements in the CRQ at 3 months as
compared to baseline and maintained these improvements
at 12 months.
Exercise capacity
Table 5 contains exercise capacity results. Over 12 months
of follow-up, neither _VO2 peak nor total treadmill time was
significantly different between the groups. There were no
significant differences in either measure between the two
groups at any of the follow-up time points.Serious adverse events
Serious adverse events for each intervention arm are pre-
sented in Table 6. Twenty-three of the participants in the
TET group and 24 of the participants in the LAP group
Table 3 Physical function outcomes by intervention arm at baseline and follow-up.
Variable Baseline 3 Mo 6 Mo 12 Mo P value TET vs LAP,
average effect across
all follow-up visits
Six-min walk (m)
TET 410.7 428.7  8.3 (0.03) 439.8  9.9 (<0.01) 430.5  10.0 (0.05) 0.41
LAP 410.7 434.8  8.8 (<0.01) 426.7  10.3 (0.12) 408.1  10.5 (0.81)
P value, TET vs LAP 0.61 0.36 0.13
Stair climb (sec)
TET 15.1 14.0  0.5 (0.02) 14.1  0.6 (0.07) 14.3  0.6 (0.17) 0.54
LAP 15.1 14.7  0.5 (0.37) 14.6  0.6 (0.39) 14.5  0.6 (0.30)
P value, TET vs LAP 0.36 0.52 0.83
SPPB
TET 10.6 11.0  0.2 (0.01) 11.0  0.2 (0.04) 11.2  0.2 (<0.01) 0.61
LAP 10.6 11.0  0.2 (0.03) 11.4  0.2 <0.01) 11.1  0.2 (<0.01)
P value, TET vs LAP 0.89 0.11 0.81
Four meter
walk (sec)
TET 3.9 3.5  0.1 (<0.01) 3.6  0.1 (<0.01) 3.5  0.1 (<0.01) 0.80
LAP 3.9 3.6  0.1 (<0.01) 3.5  0.1 (<0.01) 3.5  0.1 (<0.01)
P value, TET vs LAP 0.68 0.54 0.73
Chair rise (sec)
TET 12.8 10.2  0.4 (<0.01) 9.8  0.4 (<0.01) 10.3  0.4 (<0.01) 0.74
LAP 12.8 10.5  0.4 (<0.01) 10.1  0.4 (<0.01) 10.0  0.4 (<0.01)
P value, TET vs LAP 0.49 0.53 0.64
Balance (sec)
TET 29.1 28.6  0.3 (0.09) 28.8  0.4 (0.38) 29.1  0.3 (0.98) 0.10
LAP 29.1 29.3  0.4 (0.71) 29.6  0.4 (0.20) 29.6  0.3 (0.12)
P value, TET vs LAP 0.16 0.13 0.27
All values are estimated least squares means (standard error of the mean) from repeated measures analysis of covariance adjusted for
gender and baseline value. Baseline value is overall mean used to obtain least squares means at follow-up visits. P values for within
group analysis comparing follow-up visits to baseline values are reported adjacent to individual mean values.
836 M.J. Berry et al.reported at least one serious adverse event. There was no
significant differences between the two interventions in
the number of participants reporting serious adverse events
(p Z 0.92).Figure 3 Self-reported disability by intervention arm at
baseline and follow-up. Data are reported as mean  standard
error of the mean. Means were estimated from mixed effects
analysis of covariance for repeated measures adjusted for
gender and baseline values.Discussion
The results are somewhat surprising as they show no
difference in physical activity levels and secondary
outcomes at one year between patients in the TET and
LAP. Because interventions that have used similar
cognitive-behavioral strategies have been shown to be
effective in the promotion and maintenance of physical
activity in healthy older adults and those with cardiovas-
cular disease,7,26,41 we hypothesized that the LAP
participants would exhibit higher physical activity levels
versus those in the TET at the end of the trial. Our results
did show the LAP group to have higher activity levels at 12
months as compared to their baseline values and the TET
group showed a trend (pZ 0.09) for higher activity levels
at 12 months as compared to baseline. We also thought
that the LAP participants would maintain the benefits in
secondary outcomes, whereas the TET participants would
experience a loss. Our results showed both groups main-
taining a number of improvements in physical function
and quality of life at 12 months when compared to
baseline.
While most studies show a return of health benefits to
baseline values in follow-up testing following termination
of a structured rehabilitation program similar to our TET,
some studies have shown that participants maintain these
Table 4 Quality of life measures by intervention arm at baseline and follow-up.
Variable Baseline 3 Mo 6 Mo 12 Mo P value TET vs LAP,
average effect across
all follow-up visits
CESD
TET 11.6 10.8  0.9 (0.36) 11.5  0.9 (0.89) 13.0  1.0 (0.18) 0.82
LAP 11.6 12.0  1.0 (0.73) 12.3  0.9 (0.51) 11.8  1.1 (0.87)
P value, TET vs LAP 0.38 0.57 0.43
SF-36 e Physical scale
TET 34.9 36.7  0.9 (0.03) 36.5  0.9 (0.08) 36.2  1.1 (0.23) 0.45
LAP 34.9 36.0  0.9 (0.22) 35.7  1.0 (0.40) 35.2  1.2 (0.77)
P value, TET vs LAP 0.55 0.54 0.55
SF-36 e Mental scale
TET 51.6 51.9  1.0 (0.80) 52.3  1.0 (0.49) 51.1  1.1 (0.65) 0.50
LAP 51.6 51.3  1.1 (0.79) 51.1  1.0 (0.64) 50.3  1.2 (0.29)
P value, TET vs LAP 0.71 0.42 0.64
CRQ
TET 4.3 4.8  0.1 (<0.01) 4.7  0.1 (<0.01) 4.6  0.1 (0.02) 0.32
LAP 4.3 4.6  0.1 (<0.01) 4.5  0.1 (0.04) 4.6  0.1 (0.03)
P value, TET vs LAP 0.11 0.27 0.98
All values are estimated least squares means (standard error of the mean) from repeated measures analysis of covariance adjusted for
gender and baseline value. Baseline value is overall mean used to obtain least squares means at follow-up visits. CESD is the Center for
Epidemiological Studies Depression scale. SF-36 is the Medical Outcomes Study 36-item Short Form. The CRQ is the Chronic Respiratory
Disease Questionnaire. P values for within group analysis comparing follow-up visits to baseline values are reported adjacent to indi-
vidual mean values.
Lifestyle activity in COPD patients 837benefits. Casaburi et al. examined endurance time in COPD
patients randomized to either an 8 week pulmonary reha-
bilitation program while receiving tiotropium or an 8 week
pulmonary rehabilitation program while receiving
a placebo.9 Their results showed that all patients, regard-
less of treatment, maintained improvements in exercise
capacity 3 months after the completion of the pulmonary
rehabilitation program. In a follow-up paper, they found
that 3 months following the completion of the program
patients in the placebo group were at activity levels similar
to those reported during the program.17 Thus, it appears
that over the short-term COPD patients do maintain
increases in physical activity levels following an exercise
rehabilitation program and this is accompanied with the
maintenance of exercise therapy derived benefits.Table 5 Exercise capacity measures by intervention arm at bas
Variable Baseline 3 Mo
VO2 peak (ml/kg/min)
TET 14.4 14.9  0.6 (0.42)
LAP 14.4 15.2  0.6 (0.14)
P value, TET vs LAP 0.65
Total treadmill
time (s)
TET 335 416  14 (0.09)
LAP 335 411  14 (0.21)
P value, TET vs LAP 0.79
All values are estimated least squares means (standard error of the m
gender and baseline value. VO2 peak is peak oxygen consumption. Bas
follow-up visits. P values for within group analysis comparing follow-up
values.Our results and those of Casaburi et al. show that
participants in exercise rehabilitation programs can main-
tain physical activity levels and associated benefits 3e9
months following the completion of such a program. There
is evidence that these benefits are not maintained much
beyond 12e24 months.5,33 Ries et al. evaluated the efficacy
of a 12 month telephone-based maintenance program in
COPD patients that had completed an eight week rehabili-
tation program.33 During the 12 month intervention, they
found exercise tolerance and overall health status was
better maintained in the experimental group. By 24
months, these group differences had disappeared, and
patients returned to levels close to baseline values. The
authors concluded that a maintenance program consisting
of weekly calls and monthly supervised sessions producedeline and follow-up.
12 Mo P value TET vs LAP, average
effect across all follow-up visits
16.5  0.8 (0.01) 0.23
14.3  0.8 (0.87)
0.06
427  20 (0.08) 0.73
419  21 (0.22)
0.75
ean) from repeated measures analysis of covariance adjusted for
eline value is overall mean used to obtain least squares means at
visits to baseline values are reported adjacent to individual mean
Table 6 Serious adverse events by intervention arm.
TET LAP P Value
Serious adverse event
Cardiac 7 5 0.58
Dental 1 0 1.00
Gastrointestinal 2 1 1.00
Genitourinary/
Reproductive
1 4 0.21
Lymphatic 1 0 1.00
Metabolic 1 0 1.00
Musculoskeletal 2 1 1.00
Neurologic 2 1 1.00
Pulmonary 8 13 0.22
Values are the number of events. The p values for comparing
the two treatment arms were obtained using the Chi-square
test for categorical variables.
838 M.J. Berry et al.only modest improvements in the maintenance of benefits
following rehabilitation and that these improvements are
not durable in the absence of an ongoing intervention. In
retrospect, it would have been informative to extend out
study out to 24 months to examine group differences at this
more distant time point.
In a previous trial, we reported on patients who completed
a 3 or 18 month center-based exercise intervention.5 Those in
the 3-month intervention were encouraged to continue
exercising; however, they were not provided with the
opportunity to continue at our center. At the end of 18
months, those in the 3-month intervention reported lower
levels of physical activity, physical function and a reduced
quality of life as compared to those in the 18 month program.
More importantly, those in the 18 month intervention main-
tained the early benefits archived from participating.
Recently, Steele and colleagues evaluated the efficacy of a 12
week exercise adherence intervention initiated after patients
completed an 8 week rehabilitation program.36 As compared
to a control group that only completed the 8 week rehabili-
tation program, those patients in the exercise adherence
intervention had smaller declines in exercise adherence and
exercise capacity at the completion of the 12 week exercise
adherence intervention. However, at one year of follow-up,
there were no differences between the groups in daily
activity levels, and there were no long-term benefits with
respect to exercise capacity. Based on the results of these
previously published studies and this investigation, it appears
that COPD patients who participate in short-term exercise
therapyprogramscanmaintain thebenefits for up tooneyear.
However, following that, it appears that the benefits begin to
diminish as time progresses. Collectively, this research points
to the need for intervention studies that examine adherence
2e4 years following the onset of treatment and to formally
test behavioral interventions that directly address the ques-
tion of how to best promote long-term adherence.
A limitation with the current study is the lack of a control
group that received no exercise intervention. Given previous
studies documenting the effectiveness of exercise at
improving physical function in COPD patients, we did not
feel it would be ethical to withhold a proven treatment.
Since both the TET and LAP had similar levels of physical
activity and physical function at the completion of the trial,it could be argued that neither intervention was effective at
increasing physical activity or improvement secondary
outcomes. However, despite the fact that there were no
group differences between the LAT and TET both groups did
improve their physical activity habits from baseline to
follow-up assessments and this was complemented by
improvement in selected measures of physical function and
quality of life. Results from previous studies have shown that
physical function will decline in COPD patients not involved
in exercise. Stav et al. followed patients assigned to either
a three year pulmonary rehabilitation program versus a no
exercise control group. At the end of one, two, and three
years, physical function had declined in the control group,
whereas physical function was improved and maintained
throughout the study in the exercise group.35
An additional limitation to our study is the fact that
traditional measures used in evaluating the efficacy of
pulmonary rehabilitation (i.e, 6minwalk and the CRQ) did not
show clinically meaningful improvements at 3 or 12 months.
Our interventions were designed so that both groups had
similar exercise prescriptions while performing center-based
exercise.We set these levels so that those in the LAPwould be
able tomimic these same levelswhen exercising unsupervised
at home. While it may be argued that these intensity levels
were too low to elicit clinically meaningful improvements in
traditionalmeasures used in pulmonary rehabilitation, we did
see clinicallymeaningful changes in the SPPB in both groups at
12 months.19,24 Given the SPPB is a valid measure of lower
extremity function that has beenusedwithCOPDpatients,we
would argue that both interventions, albeit while not signifi-
cantly different from each other, were effective in improving
long-term physical function.
In conclusion, this study shows that a LAP approach to
exercise therapy with COPD patients is safe and effective at
maintaining increased physical activity levels at one year.
Additionally, both the LAP and TET result in the mainte-
nance of selected health benefits at one year. It is impor-
tant to note that all participants in this study had to pass
a behavior run-in prior to being deemed eligible for
participation. This is relevant to the external validity of the
study results. Additional intervention research is needed to
determine whether the long-term effects of LAP and TET on
exercise adherence and health benefits in patients with
COPD extend beyond 12 months.
Conflict of interest statement
No conflict of interest were reported for any of the authors.References
1. American College of Sports Medicine Position Stand. Exercise
and physical activity for older adults. Med Sci Sports Exerc
1998;30:992e1008.
2. American Thoracic Society. ATS statement: guidelines for the six-
minute walk test. Am J Respir Crit Care Med 2002;166:111e7.
3. American Thoracic Society. Standardization of spirometry e
1987 update. Am Rev Respir Dis 1987;136:1285e98.
4. Berry MJ, Adair NE, Rejeski WJ. Use of peak oxygen
consumption in predicting physical function and quality of life
in COPD patients. Chest 2006;129:1516e22.
Lifestyle activity in COPD patients 8395. Berry MJ, Rejeski WJ, Adair NE, Ettinger Jr WH, Zaccaro DJ,
Sevick MA. A randomized, controlled trial comparing long-term
and short-term exercise in patients with chronic obstructive
pulmonary disease. J Cardiopulm Rehabil 2003;23:60e8.
6. Borg GA. Psychophysical bases of perceived exertion. Med Sci
Sports Exerc 1982;14:377e81.
7. Brawley LR, Rejeski WJ, Lutes L. A group-mediated cognitive-
behavioral intervention for increasing adherence to physical
activity in older adults. J Appl Biobehav Res 2000;5:47e64.
8. Burnam MA, Wells KB, Leake B, Landsverk J. Development of
a brief screening instrument for detecting depressive disor-
ders. Med Care 1988;26:775e89.
9. Casaburi R, Kukafka D, Cooper CB, Witek Jr TJ, Kesten S.
Improvement in exercise tolerance with the combination of
tiotropium and pulmonary rehabilitation in patients with
COPD. Chest 2005;127:809e17.
10. Eisner MD, Blanc PD, Yelin EH, Sidney S, Katz PP, Ackerson L,
et al. COPD as a systemic disease: impact on physical func-
tional limitations. Am J Med 2008;121:789e96.
11. Foy CG, Rejeski WJ, Berry MJ. Gender moderates the effects of
long-term exercise therapy upon health-related quality of life
among COPD patients. Chest 2001;119:70e6.
12. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM.
Regular physical activity reduces hospital admission and
mortality in chronic obstructive pulmonary disease: a pop-
ulation based cohort study. Thorax 2006;61:772e8.
13. Garvey C. Reimbursement for pulmonary rehabilitation
[Online]. American Thoracic Society; 2007.
14. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS,
Ostir GV, et al. Lower extremity function and subsequent
disability: consistency across studies, predictive models, and
value of gait speed alone compared with the short physical
performance battery. J Gerontol A Biol Sci Med Sci 2000;55:
M221eM231.
15. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF,
Blazer DG, et al. A short physical performance battery
assessing lower extremity function: association with self-
reported disability and prediction of mortality and nursing
home admission. J Gerontol 1994;49:M85eM94.
16. Guyatt GH, Berman LB, Townsend M, Pugsley SO,
Chambers LW. A measure of quality of life for clinical trials in
chronic lung disease. Thorax 1987;42:773e8.
17. Kesten S, Casaburi R, Kukafka D, Cooper CB. Improvement in
self-reported exercise participation with the combination of
tiotropium and rehabilitative exercise training in COPD
patients. Int J Chron Obstruct Pulmon Dis 2008;3:127e36.
18. King AC, Pruitt LA, Phillips W, Oka R, Rodenburg A, Haskell WL.
Comparative effects of two physical activity programs on
measured and perceived physical functioning and other health-
related quality of life outcomes in older adults. J Gerontol A
Biol Sci Med Sci 2000;55:M74eM83.
19. Kwon S, Perera S, Pahor M, Katula JA, King AC, Groessl EJ,
et al. What is a meaningful change in physical performance?
Findings from a clinical trial in older adults (the LIFE-P study).
J Nutr Health Aging 2009;13:538e44.
20. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary
rehabilitation for chronic obstructive pulmonary disease.
Cochrane Database Syst Rev; 2006:CD003793.
21. Lacasse Y, Guyatt GH, Goldstein RS. The components of
a respiratory rehabilitation program: a systematic overview.
Chest 1997;111:1077e88.
22. McGlone S, Venn A, Walters EH, Wood-Baker R. Physical
activity, spirometry and quality-of-life in chronic obstructive
pulmonary disease. COPD 2006;3:83e8.
23. Oldridge NB, Streiner DL. The health belief model: predicting
compliance and dropout in cardiac rehabilitation. Med Sci
Sports Exerc 1990;22:678e83.24. Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful
change and responsiveness in common physical performance
measures in older adults. J Am Geriatr Soc 2006;54:743e9.
25. Pitta F, Troosters T, Spruit MA, Probst VS, DeCramer M,
Gosselink R. Characteristics of physical activities in daily life in
chronic obstructive pulmonary disease. Am J Respir Crit Care
Med 2005;171:972e7.
26. Rejeski WJ, Brawley LR, Ambrosius WT, Brubaker PH, Focht BC,
Foy CG, et al. Older adults with chronic disease: benefits of
group-mediated counseling in the promotion of physically
active lifestyles. Health Psychol 2003;22:414e23.
27. Rejeski WJ, Ettinger WHJ, Schumaker S, James P, Burns R,
Elam JT. Assessing performance-related disability in patients
with knee osteoarthritis. Osteoarthr Cartil 1995;3:157e67.
28. Rejeski WJ, Foley KO, Woodard CM, Zaccaro DJ, Berry MJ.
Evaluating and understanding performance testing in COPD
patients. J Cardiopulm Rehabil 2000;20:79e88.
29. Rejeski WJ, Ip EH, Marsh AP, Miller ME, Farmer DF. Measuring
disability in older adults: the International Classification
System of Functioning, Disability and Health (ICF) framework.
Geriatr Gerontol Int 2008;8:48e54.
30. Rennard S, DeCramer M, Calverley PM, Pride NB, Soriano JB,
Vermeire PA, et al. Impact of COPD in North America and
Europe in 2000: subjects’ perspective of Confronting COPD
International Survey. Eur Respir J 2002;20:799e805.
31. Resnick B, King A, Riebe D, Ory M. Measuring physical activity
in older adults: use of the Community Health Activities Model
Program for Seniors Physical Activity Questionnaire and the
Yale Physical Activity Survey in three behavior change
consortium studies. West J Nurs Res 2008;30:673e89.
32. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF,
Mahler DA, et al. Pulmonary rehabilitation: joint ACCP/AACVPR
evidence-based clinical practice guidelines. Chest 2007;131:
4Se42S.
33. Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after
pulmonary rehabilitation in chronic lung disease: a randomized
trial. Am J Respir Crit Care Med 2003;167:880e8.
34. Serres I, Gautier V, Varray A, Prefaut C. Impaired skeletal
muscle endurance related to physical inactivity and altered
lung function in COPD patients. Chest 1998;113:900e5.
35. Stav D, Raz M, Shpirer I. Three years of pulmonary rehabilita-
tion: inhibit the decline in airflow obstruction, improves
exercise endurance time, and body-mass index, in chronic
obstructive pulmonary disease. BMC Pulm Med 2009;9:26.
36. Steele BG, Belza B, Cain KC, Coppersmith J, Lakshminarayan S,
Howard J, et al. A randomized clinical trial of an activity and
exercise adherence intervention in chronic pulmonary disease.
Arch Phys Med Rehabil 2008;89:404e12.
37. Stewart AL, Hays RD, Ware JEJ. The MOS short-form general
health survey. Reliability and validity in a patient population.
Med Care 1988;26:724e35.
38. Stewart AL, Mills KM, King AC, Haskell WL, Gillis D, Ritter PL.
CHAMPS physical activity questionnaire for older adults:
outcomes for interventions. Med Sci Sports Exerc 2001;33:
1126e41.
39. Stewart AL, Mills KM, Sepsis PG, King AC, McLellan BY, Roitz K,
et al. Evaluation of CHAMPS, a physical activity promotion
program for older adults. Ann Behav Med 1997;19:353e61.
40. U.S. Department of Health and Human Services. Physical
activity and health: a report of the surgeon general, vol. 33.
Atlanta, GA: U.S, Centers for Disease Control and Prevention,
National Center for Chronic Disease Prevention and Health
Promotion; 1996.
41. Wilcox S, Dowda M, Leviton LC, Bartlett-Prescott J, Bazzarre T,
Campbell-Voytal K, et al. Active for life: final results from the
translation of two physical activity programs. Am J Prev Med
2008;35:340e51.
